

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle exocytosis (GO:0016079) | 5.90641161 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.31327958 |
| 3 | neuronal action potential propagation (GO:0019227) | 5.15553378 |
| 4 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.12691166 |
| 5 | vocalization behavior (GO:0071625) | 5.03151990 |
| 6 | cellular potassium ion homeostasis (GO:0030007) | 4.98017827 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.96953568 |
| 8 | synaptic vesicle maturation (GO:0016188) | 4.82170264 |
| 9 | neurotransmitter secretion (GO:0007269) | 4.78379826 |
| 10 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.76645387 |
| 11 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.74864700 |
| 12 | cellular ketone body metabolic process (GO:0046950) | 4.74319907 |
| 13 | glutamate secretion (GO:0014047) | 4.67153392 |
| 14 | positive regulation of synapse maturation (GO:0090129) | 4.63509220 |
| 15 | locomotory exploration behavior (GO:0035641) | 4.61648008 |
| 16 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.49241174 |
| 17 | regulation of synaptic vesicle transport (GO:1902803) | 4.44426578 |
| 18 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.44024651 |
| 19 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.40666642 |
| 20 | inositol phosphate catabolic process (GO:0071545) | 4.35224776 |
| 21 | cerebellar Purkinje cell differentiation (GO:0021702) | 4.35100664 |
| 22 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.31354991 |
| 23 | insulin secretion (GO:0030073) | 4.24594036 |
| 24 | lactate metabolic process (GO:0006089) | 4.24229491 |
| 25 | glycerophospholipid catabolic process (GO:0046475) | 4.22284757 |
| 26 | respiratory chain complex IV assembly (GO:0008535) | 4.20441459 |
| 27 | gamma-aminobutyric acid transport (GO:0015812) | 4.18660369 |
| 28 | ketone body metabolic process (GO:1902224) | 4.18146776 |
| 29 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.12706715 |
| 30 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.12174745 |
| 31 | negative regulation of execution phase of apoptosis (GO:1900118) | 4.12107046 |
| 32 | neuron-neuron synaptic transmission (GO:0007270) | 4.06158562 |
| 33 | regulation of glucokinase activity (GO:0033131) | 4.05703457 |
| 34 | regulation of hexokinase activity (GO:1903299) | 4.05703457 |
| 35 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 4.04481256 |
| 36 | protein localization to synapse (GO:0035418) | 4.02989573 |
| 37 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.97856328 |
| 38 | inositol phosphate dephosphorylation (GO:0046855) | 3.97856328 |
| 39 | neurotransmitter transport (GO:0006836) | 3.94066460 |
| 40 | synaptic transmission, glutamatergic (GO:0035249) | 3.90647082 |
| 41 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.90618763 |
| 42 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.89581889 |
| 43 | negative regulation of protein oligomerization (GO:0032460) | 3.87861023 |
| 44 | neuron cell-cell adhesion (GO:0007158) | 3.87451051 |
| 45 | endocrine pancreas development (GO:0031018) | 3.86655646 |
| 46 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.84956747 |
| 47 | peptide hormone processing (GO:0016486) | 3.81544817 |
| 48 | synaptic vesicle endocytosis (GO:0048488) | 3.81176287 |
| 49 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.81160352 |
| 50 | regulation of neurotransmitter uptake (GO:0051580) | 3.80255564 |
| 51 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.79251858 |
| 52 | glutamate receptor signaling pathway (GO:0007215) | 3.78173544 |
| 53 | neuromuscular process controlling posture (GO:0050884) | 3.76321427 |
| 54 | dendritic spine morphogenesis (GO:0060997) | 3.75922131 |
| 55 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.73594309 |
| 56 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.72876098 |
| 57 | long-term memory (GO:0007616) | 3.69516701 |
| 58 | cerebellar granule cell differentiation (GO:0021707) | 3.68990851 |
| 59 | regulation of synapse maturation (GO:0090128) | 3.66415384 |
| 60 | cytochrome complex assembly (GO:0017004) | 3.63555551 |
| 61 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.61023621 |
| 62 | potassium ion homeostasis (GO:0055075) | 3.57459763 |
| 63 | sodium ion export (GO:0071436) | 3.55891478 |
| 64 | response to pheromone (GO:0019236) | 3.54928075 |
| 65 | positive regulation of membrane potential (GO:0045838) | 3.50804611 |
| 66 | polyol catabolic process (GO:0046174) | 3.48962226 |
| 67 | regulation of neurotransmitter levels (GO:0001505) | 3.48314512 |
| 68 | layer formation in cerebral cortex (GO:0021819) | 3.45934510 |
| 69 | positive regulation of glycolytic process (GO:0045821) | 3.44533207 |
| 70 | long-term synaptic potentiation (GO:0060291) | 3.44421406 |
| 71 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.43850437 |
| 72 | regulation of neurotransmitter secretion (GO:0046928) | 3.41059469 |
| 73 | activation of protein kinase A activity (GO:0034199) | 3.39907767 |
| 74 | sphingomyelin metabolic process (GO:0006684) | 3.39041145 |
| 75 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 3.38508976 |
| 76 | nitric oxide biosynthetic process (GO:0006809) | 3.38280071 |
| 77 | cell differentiation in hindbrain (GO:0021533) | 3.36887689 |
| 78 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.36240416 |
| 79 | detection of calcium ion (GO:0005513) | 3.35913738 |
| 80 | negative regulation of complement activation (GO:0045916) | 3.34399397 |
| 81 | positive regulation of insulin secretion (GO:0032024) | 3.34163913 |
| 82 | exploration behavior (GO:0035640) | 3.31254558 |
| 83 | membrane depolarization during action potential (GO:0086010) | 3.29742642 |
| 84 | long term synaptic depression (GO:0060292) | 3.27584030 |
| 85 | transferrin transport (GO:0033572) | 3.26759396 |
| 86 | striatum development (GO:0021756) | 3.26581009 |
| 87 | regulation of neurotransmitter transport (GO:0051588) | 3.26097599 |
| 88 | regulation of synapse structural plasticity (GO:0051823) | 3.25789872 |
| 89 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.25766083 |
| 90 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.25349454 |
| 91 | regulation of vesicle fusion (GO:0031338) | 3.25280739 |
| 92 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.24191884 |
| 93 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.24191884 |
| 94 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.21422445 |
| 95 | nitric oxide mediated signal transduction (GO:0007263) | 3.19844957 |
| 96 | innervation (GO:0060384) | 3.18325574 |
| 97 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.18166905 |
| 98 | synaptic vesicle transport (GO:0048489) | 3.18055668 |
| 99 | establishment of synaptic vesicle localization (GO:0097480) | 3.18055668 |
| 100 | synaptic transmission (GO:0007268) | 3.17828192 |
| 101 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.17196932 |
| 102 | succinate metabolic process (GO:0006105) | 3.16068016 |
| 103 | cell communication by electrical coupling (GO:0010644) | 3.16015361 |
| 104 | auditory receptor cell differentiation (GO:0042491) | 3.14848380 |
| 105 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.14774737 |
| 106 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.13049672 |
| 107 | inositol phosphate-mediated signaling (GO:0048016) | 3.12367344 |
| 108 | positive regulation of gluconeogenesis (GO:0045722) | 3.11340360 |
| 109 | positive regulation of meiosis (GO:0045836) | 3.11262725 |
| 110 | epithelial cell fate commitment (GO:0072148) | 3.11177150 |
| 111 | positive regulation of glomerulus development (GO:0090193) | 3.10843830 |
| 112 | ferric iron transport (GO:0015682) | 3.09967321 |
| 113 | trivalent inorganic cation transport (GO:0072512) | 3.09967321 |
| 114 | regulation of postsynaptic membrane potential (GO:0060078) | 3.09468406 |
| 115 | urinary tract smooth muscle contraction (GO:0014848) | 3.09185828 |
| 116 | positive regulation of peptide hormone secretion (GO:0090277) | 3.05968755 |
| 117 | positive regulation of histone H3-K4 methylation (GO:0051571) | 3.05342354 |
| 118 | membrane hyperpolarization (GO:0060081) | 3.04863403 |
| 119 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 3.03502824 |
| 120 | transmission of nerve impulse (GO:0019226) | 3.02265486 |
| 121 | signal peptide processing (GO:0006465) | 3.02023482 |
| 122 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 3.01905820 |
| 123 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.00304087 |
| 124 | adult walking behavior (GO:0007628) | 2.98527018 |
| 125 | renal tubule morphogenesis (GO:0061333) | 2.98280473 |
| 126 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.97212284 |
| 127 | positive regulation of peptide secretion (GO:0002793) | 2.94921933 |
| 128 | negative regulation of protein activation cascade (GO:2000258) | 2.93849974 |
| 129 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.93756831 |
| 130 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.93216901 |
| 131 | kidney morphogenesis (GO:0060993) | 2.93175810 |
| 132 | membrane depolarization (GO:0051899) | 2.91653703 |
| 133 | regulation of insulin secretion (GO:0050796) | 2.90375673 |
| 134 | aggressive behavior (GO:0002118) | 2.89571833 |
| 135 | dopamine transport (GO:0015872) | 2.88438352 |
| 136 | platelet dense granule organization (GO:0060155) | 2.88335363 |
| 137 | regulation of synaptic plasticity (GO:0048167) | 2.88275678 |
| 138 | signal release (GO:0023061) | 2.88256008 |
| 139 | positive regulation of meiotic cell cycle (GO:0051446) | 2.88055510 |
| 140 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.87964198 |
| 141 | detection of light stimulus involved in visual perception (GO:0050908) | 2.87964198 |
| 142 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.87658753 |
| 143 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.87014728 |
| 144 | zinc ion homeostasis (GO:0055069) | 2.84247009 |
| 145 | synapse assembly (GO:0007416) | 2.82844005 |
| 146 | proline transport (GO:0015824) | 2.82301856 |
| 147 | positive regulation of synaptic transmission (GO:0050806) | 2.81355036 |
| 148 | regulation of synaptic transmission (GO:0050804) | 2.80425626 |
| 149 | macroautophagy (GO:0016236) | 2.77143561 |
| 150 | establishment of vesicle localization (GO:0051650) | 2.76081692 |
| 151 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.75856381 |
| 152 | cerebellar Purkinje cell layer development (GO:0021680) | 2.75735693 |
| 153 | positive regulation of calcium ion import (GO:0090280) | 2.75529607 |
| 154 | potassium ion transmembrane transport (GO:0071805) | 2.74670433 |
| 155 | cardiac left ventricle morphogenesis (GO:0003214) | 2.73243612 |
| 156 | peptide hormone secretion (GO:0030072) | 2.73118969 |
| 157 | myelin maintenance (GO:0043217) | 2.68081678 |
| 158 | protein complex biogenesis (GO:0070271) | 2.67422130 |
| 159 | positive regulation of actin filament depolymerization (GO:0030836) | 2.67402064 |
| 160 | regulation of peptide hormone secretion (GO:0090276) | 2.66956631 |
| 161 | peptide secretion (GO:0002790) | 2.63260075 |
| 162 | axoneme assembly (GO:0035082) | 2.62657331 |
| 163 | regulation of peptide secretion (GO:0002791) | 2.62078778 |
| 164 | dentate gyrus development (GO:0021542) | 2.61969509 |
| 165 | negative regulation of hormone metabolic process (GO:0032351) | 2.61650445 |
| 166 | glandular epithelial cell differentiation (GO:0002067) | 2.60738137 |
| 167 | peptidyl-cysteine modification (GO:0018198) | 2.60414820 |
| 168 | negative regulation of dendrite development (GO:2000171) | 2.56631367 |
| 169 | negative regulation of neurological system process (GO:0031645) | 2.56098376 |
| 170 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.55195139 |
| 171 | thyroid hormone metabolic process (GO:0042403) | 2.55104925 |
| 172 | toxin transport (GO:1901998) | 2.53015971 |
| 173 | protein prenylation (GO:0018342) | 2.52701498 |
| 174 | prenylation (GO:0097354) | 2.52701498 |
| 175 | L-phenylalanine catabolic process (GO:0006559) | 2.50988533 |
| 176 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.50988533 |
| 177 | catecholamine transport (GO:0051937) | 2.49841866 |
| 178 | cellular zinc ion homeostasis (GO:0006882) | 2.49241211 |
| 179 | retinol metabolic process (GO:0042572) | 2.49015867 |
| 180 | phospholipid catabolic process (GO:0009395) | 2.48857544 |
| 181 | zinc ion transmembrane transport (GO:0071577) | 2.48342370 |
| 182 | fatty acid homeostasis (GO:0055089) | 2.47322566 |
| 183 | chemosensory behavior (GO:0007635) | 2.46650559 |
| 184 | negative regulation of humoral immune response (GO:0002921) | 2.45596965 |
| 185 | nephron tubule morphogenesis (GO:0072078) | 2.45586433 |
| 186 | nephron epithelium morphogenesis (GO:0072088) | 2.45586433 |
| 187 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.44160757 |
| 188 | potassium ion export (GO:0071435) | 2.43320413 |
| 189 | positive regulation of protein autophosphorylation (GO:0031954) | 2.43217095 |
| 190 | response to amphetamine (GO:0001975) | 2.40476123 |
| 191 | sequestering of metal ion (GO:0051238) | 2.38667616 |
| 192 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.38599156 |
| 193 | regulation of hormone secretion (GO:0046883) | 2.38423594 |
| 194 | positive regulation of macroautophagy (GO:0016239) | 2.37604541 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 7.60792965 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.94467675 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.11064474 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.16679366 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.11774309 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 3.01433825 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.94020183 |
| 8 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.62757638 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.57238252 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.57238252 |
| 11 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.57104843 |
| 12 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.56738461 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.52859079 |
| 14 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.49668920 |
| 15 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.47433433 |
| 16 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.38594001 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.38378851 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.30263686 |
| 19 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.29911076 |
| 20 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.26741957 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.26731112 |
| 22 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.19419172 |
| 23 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.18307786 |
| 24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.17684379 |
| 25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.11462307 |
| 26 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.08826214 |
| 27 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.03748985 |
| 28 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.03025042 |
| 29 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 2.01805307 |
| 30 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.00841720 |
| 31 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.94105411 |
| 32 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.87784018 |
| 33 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.87227807 |
| 34 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.83242447 |
| 35 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.79650284 |
| 36 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.78473559 |
| 37 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.73671389 |
| 38 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.72457310 |
| 39 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.70429518 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.69406726 |
| 41 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.68856640 |
| 42 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.67862696 |
| 43 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.63422923 |
| 44 | P300_19829295_ChIP-Seq_ESCs_Human | 1.52901796 |
| 45 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.51352289 |
| 46 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.48501202 |
| 47 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.46296780 |
| 48 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.45226907 |
| 49 | AR_25329375_ChIP-Seq_VCAP_Human | 1.43312745 |
| 50 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.42762478 |
| 51 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.42735821 |
| 52 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.40115351 |
| 53 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.39630978 |
| 54 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.39218259 |
| 55 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.38736176 |
| 56 | STAT3_23295773_ChIP-Seq_U87_Human | 1.38007190 |
| 57 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.37805890 |
| 58 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.35930947 |
| 59 | EWS_26573619_Chip-Seq_HEK293_Human | 1.35049017 |
| 60 | VDR_22108803_ChIP-Seq_LS180_Human | 1.33778792 |
| 61 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.33468760 |
| 62 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.32863464 |
| 63 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.32510922 |
| 64 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.31447916 |
| 65 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.30477219 |
| 66 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.29869925 |
| 67 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.29333379 |
| 68 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.28755790 |
| 69 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.27964404 |
| 70 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.26732715 |
| 71 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.26732715 |
| 72 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.26708020 |
| 73 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.25938253 |
| 74 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.25938253 |
| 75 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.23857067 |
| 76 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.23848007 |
| 77 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.23138952 |
| 78 | AR_19668381_ChIP-Seq_PC3_Human | 1.22445948 |
| 79 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.21462338 |
| 80 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.21232161 |
| 81 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.21160329 |
| 82 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.20394443 |
| 83 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.20394443 |
| 84 | TCF4_23295773_ChIP-Seq_U87_Human | 1.19465975 |
| 85 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.18555628 |
| 86 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.17944838 |
| 87 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.17824805 |
| 88 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.16950356 |
| 89 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.15991789 |
| 90 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.15765228 |
| 91 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.14215028 |
| 92 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.13313144 |
| 93 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.12502419 |
| 94 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.12302573 |
| 95 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.12118727 |
| 96 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.12071828 |
| 97 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.11922899 |
| 98 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.10675556 |
| 99 | FUS_26573619_Chip-Seq_HEK293_Human | 1.10439362 |
| 100 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.09789417 |
| 101 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.08984414 |
| 102 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.08723362 |
| 103 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.07879029 |
| 104 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.07656868 |
| 105 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.07045659 |
| 106 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.06973167 |
| 107 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.06623462 |
| 108 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.06582984 |
| 109 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.06140160 |
| 110 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.05364791 |
| 111 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.04759795 |
| 112 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.01438755 |
| 113 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.00939170 |
| 114 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.00524660 |
| 115 | NCOR_22424771_ChIP-Seq_293T_Human | 0.99731480 |
| 116 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.99082755 |
| 117 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.98923403 |
| 118 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97821006 |
| 119 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.97431384 |
| 120 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.96649479 |
| 121 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.96444087 |
| 122 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.96083771 |
| 123 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95099721 |
| 124 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.95016547 |
| 125 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.94997160 |
| 126 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.94877626 |
| 127 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.94807017 |
| 128 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.94309184 |
| 129 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.94080378 |
| 130 | JUN_21703547_ChIP-Seq_K562_Human | 0.93041623 |
| 131 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.92913420 |
| 132 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.91999097 |
| 133 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.91548431 |
| 134 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.91298325 |
| 135 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91249791 |
| 136 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.90988611 |
| 137 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.87758594 |
| 138 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.86413995 |
| 139 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.86223726 |
| 140 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.85584499 |
| 141 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.85508996 |
| 142 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.85418475 |
| 143 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.85375874 |
| 144 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85221487 |
| 145 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84778213 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.01959210 |
| 2 | MP0005379_endocrine/exocrine_gland_phen | 4.22332956 |
| 3 | MP0009046_muscle_twitch | 4.04034999 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.73577605 |
| 5 | MP0002163_abnormal_gland_morphology | 3.44357653 |
| 6 | MP0003880_abnormal_central_pattern | 3.29143339 |
| 7 | MP0002064_seizures | 3.13474250 |
| 8 | MP0009745_abnormal_behavioral_response | 3.11650974 |
| 9 | MP0004270_analgesia | 2.95166907 |
| 10 | MP0002272_abnormal_nervous_system | 2.91490134 |
| 11 | MP0010234_abnormal_vibrissa_follicle | 2.87128043 |
| 12 | MP0002063_abnormal_learning/memory/cond | 2.82112821 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.70379669 |
| 14 | MP0002822_catalepsy | 2.67324211 |
| 15 | MP0002572_abnormal_emotion/affect_behav | 2.53898076 |
| 16 | MP0002139_abnormal_hepatobiliary_system | 2.38406840 |
| 17 | MP0001968_abnormal_touch/_nociception | 2.38375873 |
| 18 | MP0001486_abnormal_startle_reflex | 2.36598858 |
| 19 | MP0008569_lethality_at_weaning | 2.35666403 |
| 20 | MP0001501_abnormal_sleep_pattern | 2.35654222 |
| 21 | MP0005551_abnormal_eye_electrophysiolog | 2.29747668 |
| 22 | MP0010386_abnormal_urinary_bladder | 2.27166452 |
| 23 | MP0002909_abnormal_adrenal_gland | 2.25446458 |
| 24 | MP0002067_abnormal_sensory_capabilities | 2.25054423 |
| 25 | MP0001984_abnormal_olfaction | 2.20231168 |
| 26 | MP0002735_abnormal_chemical_nociception | 2.10641073 |
| 27 | MP0002736_abnormal_nociception_after | 2.06465617 |
| 28 | MP0001440_abnormal_grooming_behavior | 2.04088930 |
| 29 | MP0003195_calcinosis | 2.02257100 |
| 30 | MP0002184_abnormal_innervation | 1.95300889 |
| 31 | MP0002638_abnormal_pupillary_reflex | 1.88065221 |
| 32 | MP0008875_abnormal_xenobiotic_pharmacok | 1.85142034 |
| 33 | MP0009780_abnormal_chondrocyte_physiolo | 1.81705499 |
| 34 | MP0005423_abnormal_somatic_nervous | 1.77106334 |
| 35 | MP0001970_abnormal_pain_threshold | 1.76938787 |
| 36 | MP0003879_abnormal_hair_cell | 1.76225658 |
| 37 | MP0000013_abnormal_adipose_tissue | 1.74032639 |
| 38 | MP0005646_abnormal_pituitary_gland | 1.73690981 |
| 39 | MP0010329_abnormal_lipoprotein_level | 1.73237375 |
| 40 | MP0004142_abnormal_muscle_tone | 1.72874748 |
| 41 | MP0002837_dystrophic_cardiac_calcinosis | 1.70026888 |
| 42 | MP0001502_abnormal_circadian_rhythm | 1.68618394 |
| 43 | MP0001188_hyperpigmentation | 1.65583344 |
| 44 | MP0004147_increased_porphyrin_level | 1.62940623 |
| 45 | MP0002733_abnormal_thermal_nociception | 1.62395910 |
| 46 | MP0005386_behavior/neurological_phenoty | 1.60794824 |
| 47 | MP0004924_abnormal_behavior | 1.60794824 |
| 48 | MP0005220_abnormal_exocrine_pancreas | 1.60537245 |
| 49 | MP0003172_abnormal_lysosome_physiology | 1.57386500 |
| 50 | MP0002557_abnormal_social/conspecific_i | 1.56206869 |
| 51 | MP0006072_abnormal_retinal_apoptosis | 1.54936620 |
| 52 | MP0003787_abnormal_imprinting | 1.53755822 |
| 53 | MP0004233_abnormal_muscle_weight | 1.53730901 |
| 54 | MP0006276_abnormal_autonomic_nervous | 1.52519096 |
| 55 | MP0008877_abnormal_DNA_methylation | 1.52322980 |
| 56 | MP0000955_abnormal_spinal_cord | 1.49606524 |
| 57 | MP0003329_amyloid_beta_deposits | 1.47431678 |
| 58 | MP0004043_abnormal_pH_regulation | 1.46846998 |
| 59 | MP0004811_abnormal_neuron_physiology | 1.46353741 |
| 60 | MP0005332_abnormal_amino_acid | 1.43437684 |
| 61 | MP0008995_early_reproductive_senescence | 1.42017589 |
| 62 | MP0003122_maternal_imprinting | 1.41544240 |
| 63 | MP0002229_neurodegeneration | 1.39484764 |
| 64 | MP0002882_abnormal_neuron_morphology | 1.38923422 |
| 65 | MP0001529_abnormal_vocalization | 1.37929236 |
| 66 | MP0002090_abnormal_vision | 1.36568796 |
| 67 | MP0002066_abnormal_motor_capabilities/c | 1.36480015 |
| 68 | MP0004145_abnormal_muscle_electrophysio | 1.33264098 |
| 69 | MP0004885_abnormal_endolymph | 1.30264490 |
| 70 | MP0004858_abnormal_nervous_system | 1.30217386 |
| 71 | MP0005187_abnormal_penis_morphology | 1.29931108 |
| 72 | MP0001756_abnormal_urination | 1.28621126 |
| 73 | MP0000427_abnormal_hair_cycle | 1.27038990 |
| 74 | MP0004215_abnormal_myocardial_fiber | 1.24541548 |
| 75 | MP0005636_abnormal_mineral_homeostasis | 1.23741928 |
| 76 | MP0000751_myopathy | 1.19686846 |
| 77 | MP0010678_abnormal_skin_adnexa | 1.17333249 |
| 78 | MP0005174_abnormal_tail_pigmentation | 1.16435044 |
| 79 | MP0000516_abnormal_urinary_system | 1.15049253 |
| 80 | MP0005367_renal/urinary_system_phenotyp | 1.15049253 |
| 81 | MP0003633_abnormal_nervous_system | 1.14566471 |
| 82 | MP0003011_delayed_dark_adaptation | 1.11639272 |
| 83 | MP0005645_abnormal_hypothalamus_physiol | 1.09636991 |
| 84 | MP0003121_genomic_imprinting | 1.08407570 |
| 85 | MP0004133_heterotaxia | 1.07418669 |
| 86 | MP0005499_abnormal_olfactory_system | 1.06029743 |
| 87 | MP0005394_taste/olfaction_phenotype | 1.06029743 |
| 88 | MP0005365_abnormal_bile_salt | 1.03920595 |
| 89 | MP0005389_reproductive_system_phenotype | 1.02960377 |
| 90 | MP0008872_abnormal_physiological_respon | 1.02890622 |
| 91 | MP0005448_abnormal_energy_balance | 1.02456144 |
| 92 | MP0003631_nervous_system_phenotype | 1.02194867 |
| 93 | MP0002928_abnormal_bile_duct | 1.01061024 |
| 94 | MP0000778_abnormal_nervous_system | 1.00381975 |
| 95 | MP0003953_abnormal_hormone_level | 0.98685154 |
| 96 | MP0000538_abnormal_urinary_bladder | 0.98613983 |
| 97 | MP0001905_abnormal_dopamine_level | 0.96877806 |
| 98 | MP0005253_abnormal_eye_physiology | 0.96822582 |
| 99 | MP0003283_abnormal_digestive_organ | 0.95333289 |
| 100 | MP0002876_abnormal_thyroid_physiology | 0.95202473 |
| 101 | MP0002752_abnormal_somatic_nervous | 0.94189004 |
| 102 | MP0003183_abnormal_peptide_metabolism | 0.93732032 |
| 103 | MP0003632_abnormal_nervous_system | 0.92170974 |
| 104 | MP0005535_abnormal_body_temperature | 0.91774651 |
| 105 | MP0004036_abnormal_muscle_relaxation | 0.91620787 |
| 106 | MP0008961_abnormal_basal_metabolism | 0.91522659 |
| 107 | MP0005075_abnormal_melanosome_morpholog | 0.91062143 |
| 108 | MP0004019_abnormal_vitamin_homeostasis | 0.90597922 |
| 109 | MP0003646_muscle_fatigue | 0.90512012 |
| 110 | MP0001986_abnormal_taste_sensitivity | 0.89943278 |
| 111 | MP0004085_abnormal_heartbeat | 0.89915676 |
| 112 | MP0001963_abnormal_hearing_physiology | 0.89613263 |
| 113 | MP0002152_abnormal_brain_morphology | 0.89266083 |
| 114 | MP0000015_abnormal_ear_pigmentation | 0.87591640 |
| 115 | MP0002069_abnormal_eating/drinking_beha | 0.85990070 |
| 116 | MP0005084_abnormal_gallbladder_morpholo | 0.85102954 |
| 117 | MP0004742_abnormal_vestibular_system | 0.83076656 |
| 118 | MP0002254_reproductive_system_inflammat | 0.82419199 |
| 119 | MP0000639_abnormal_adrenal_gland | 0.81464659 |
| 120 | MP0000647_abnormal_sebaceous_gland | 0.81296194 |
| 121 | MP0000631_abnormal_neuroendocrine_gland | 0.80978298 |
| 122 | MP0002118_abnormal_lipid_homeostasis | 0.80554683 |
| 123 | MP0003634_abnormal_glial_cell | 0.79900608 |
| 124 | MP0001919_abnormal_reproductive_system | 0.79622013 |
| 125 | MP0006036_abnormal_mitochondrial_physio | 0.79229573 |
| 126 | MP0001661_extended_life_span | 0.78693402 |
| 127 | MP0002160_abnormal_reproductive_system | 0.78517757 |
| 128 | MP0000613_abnormal_salivary_gland | 0.77475971 |
| 129 | MP0005248_abnormal_Harderian_gland | 0.76668121 |
| 130 | MP0002234_abnormal_pharynx_morphology | 0.72438118 |
| 131 | MP0003137_abnormal_impulse_conducting | 0.68729653 |
| 132 | MP0006292_abnormal_olfactory_placode | 0.67964272 |
| 133 | MP0001270_distended_abdomen | 0.67736961 |
| 134 | MP0005195_abnormal_posterior_eye | 0.66184181 |
| 135 | MP0001177_atelectasis | 0.66119270 |
| 136 | MP0002332_abnormal_exercise_endurance | 0.65772721 |
| 137 | MP0006035_abnormal_mitochondrial_morpho | 0.64699166 |
| 138 | MP0004484_altered_response_of | 0.64316627 |
| 139 | MP0008874_decreased_physiological_sensi | 0.62380588 |
| 140 | MP0000003_abnormal_adipose_tissue | 0.59256543 |
| 141 | MP0002078_abnormal_glucose_homeostasis | 0.57936502 |
| 142 | MP0001944_abnormal_pancreas_morphology | 0.56922068 |
| 143 | MP0001765_abnormal_ion_homeostasis | 0.56878419 |
| 144 | MP0002693_abnormal_pancreas_physiology | 0.56321862 |
| 145 | MP0001664_abnormal_digestion | 0.55884540 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.97644334 |
| 2 | Febrile seizures (HP:0002373) | 6.08276793 |
| 3 | Atonic seizures (HP:0010819) | 5.92963377 |
| 4 | Epileptic encephalopathy (HP:0200134) | 5.68230813 |
| 5 | Absence seizures (HP:0002121) | 5.32424401 |
| 6 | Myokymia (HP:0002411) | 5.20419935 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 5.10528880 |
| 8 | Visual hallucinations (HP:0002367) | 5.07080084 |
| 9 | Hypoglycemic seizures (HP:0002173) | 5.01756299 |
| 10 | Hypoglycemic coma (HP:0001325) | 4.97630479 |
| 11 | Focal seizures (HP:0007359) | 4.89438383 |
| 12 | Dialeptic seizures (HP:0011146) | 4.55991227 |
| 13 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.55689237 |
| 14 | Ketoacidosis (HP:0001993) | 4.38383076 |
| 15 | Generalized tonic-clonic seizures (HP:0002069) | 4.09920846 |
| 16 | Action tremor (HP:0002345) | 3.95889312 |
| 17 | Large for gestational age (HP:0001520) | 3.88196691 |
| 18 | Gaze-evoked nystagmus (HP:0000640) | 3.84373443 |
| 19 | Dysdiadochokinesis (HP:0002075) | 3.73242732 |
| 20 | Hyperglycemia (HP:0003074) | 3.69952208 |
| 21 | Congenital stationary night blindness (HP:0007642) | 3.49159190 |
| 22 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.33164382 |
| 23 | Symptomatic seizures (HP:0011145) | 3.23952310 |
| 24 | Pheochromocytoma (HP:0002666) | 3.23445468 |
| 25 | Abnormality of vitamin B metabolism (HP:0004340) | 3.15623049 |
| 26 | Epileptiform EEG discharges (HP:0011182) | 3.11256751 |
| 27 | Truncal ataxia (HP:0002078) | 3.10742220 |
| 28 | EEG with generalized epileptiform discharges (HP:0011198) | 3.09567600 |
| 29 | Hyperventilation (HP:0002883) | 3.08330882 |
| 30 | Late onset (HP:0003584) | 3.06463703 |
| 31 | Central scotoma (HP:0000603) | 3.03280112 |
| 32 | Dysmetric saccades (HP:0000641) | 3.03167118 |
| 33 | Intestinal atresia (HP:0011100) | 2.96494993 |
| 34 | Ketosis (HP:0001946) | 2.93828299 |
| 35 | Dysmetria (HP:0001310) | 2.91309672 |
| 36 | Enlarged penis (HP:0000040) | 2.90653747 |
| 37 | Anxiety (HP:0000739) | 2.87766098 |
| 38 | Depression (HP:0000716) | 2.87743204 |
| 39 | Scanning speech (HP:0002168) | 2.85475860 |
| 40 | Neoplasm of the adrenal cortex (HP:0100641) | 2.83943286 |
| 41 | Increased CSF protein (HP:0002922) | 2.81972055 |
| 42 | Supranuclear gaze palsy (HP:0000605) | 2.79776280 |
| 43 | Neuroendocrine neoplasm (HP:0100634) | 2.79418882 |
| 44 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.76711091 |
| 45 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.76711091 |
| 46 | Methylmalonic acidemia (HP:0002912) | 2.74751567 |
| 47 | Hemiplegia (HP:0002301) | 2.74482217 |
| 48 | Double outlet right ventricle (HP:0001719) | 2.66948154 |
| 49 | Congenital malformation of the right heart (HP:0011723) | 2.66948154 |
| 50 | Hepatic necrosis (HP:0002605) | 2.64328756 |
| 51 | Tongue fasciculations (HP:0001308) | 2.63943471 |
| 52 | Impaired smooth pursuit (HP:0007772) | 2.62719390 |
| 53 | Hypsarrhythmia (HP:0002521) | 2.62432189 |
| 54 | Abnormality of binocular vision (HP:0011514) | 2.58782453 |
| 55 | Diplopia (HP:0000651) | 2.58782453 |
| 56 | Broad-based gait (HP:0002136) | 2.58082236 |
| 57 | Hemiparesis (HP:0001269) | 2.57678195 |
| 58 | Status epilepticus (HP:0002133) | 2.57170661 |
| 59 | Hamartoma of the eye (HP:0010568) | 2.55123693 |
| 60 | Impaired social interactions (HP:0000735) | 2.52369148 |
| 61 | Abnormal social behavior (HP:0012433) | 2.52369148 |
| 62 | Hematochezia (HP:0002573) | 2.51178055 |
| 63 | Abnormality of vitamin metabolism (HP:0100508) | 2.50109359 |
| 64 | Abnormal eating behavior (HP:0100738) | 2.49788515 |
| 65 | Genetic anticipation (HP:0003743) | 2.48648493 |
| 66 | Hypokinesia (HP:0002375) | 2.46560691 |
| 67 | Urethral obstruction (HP:0000796) | 2.44245222 |
| 68 | Conjunctival hamartoma (HP:0100780) | 2.43739704 |
| 69 | Abnormality of macular pigmentation (HP:0008002) | 2.40959314 |
| 70 | Ankle clonus (HP:0011448) | 2.38750185 |
| 71 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.37394633 |
| 72 | Hypoplasia of the fovea (HP:0007750) | 2.37023001 |
| 73 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.37023001 |
| 74 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.34243530 |
| 75 | Increased CSF lactate (HP:0002490) | 2.31944125 |
| 76 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.30036879 |
| 77 | Poor eye contact (HP:0000817) | 2.29787509 |
| 78 | Postural tremor (HP:0002174) | 2.27548806 |
| 79 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.26942954 |
| 80 | Gait imbalance (HP:0002141) | 2.24706039 |
| 81 | Progressive inability to walk (HP:0002505) | 2.24614477 |
| 82 | Aqueductal stenosis (HP:0002410) | 2.24413347 |
| 83 | Amblyopia (HP:0000646) | 2.23220867 |
| 84 | Acute encephalopathy (HP:0006846) | 2.22788413 |
| 85 | Menstrual irregularities (HP:0000858) | 2.22359951 |
| 86 | Muscle fibrillation (HP:0010546) | 2.21313488 |
| 87 | Severe muscular hypotonia (HP:0006829) | 2.19657431 |
| 88 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.19632283 |
| 89 | Methylmalonic aciduria (HP:0012120) | 2.18877219 |
| 90 | Increased hepatocellular lipid droplets (HP:0006565) | 2.17162489 |
| 91 | Proximal tubulopathy (HP:0000114) | 2.15749639 |
| 92 | Abnormality of the renal cortex (HP:0011035) | 2.14962815 |
| 93 | Agitation (HP:0000713) | 2.14526904 |
| 94 | Bradykinesia (HP:0002067) | 2.13387376 |
| 95 | Glycosuria (HP:0003076) | 2.13260180 |
| 96 | Abnormality of urine glucose concentration (HP:0011016) | 2.13260180 |
| 97 | Abnormality of the lower motor neuron (HP:0002366) | 2.12907202 |
| 98 | Failure to thrive in infancy (HP:0001531) | 2.11889256 |
| 99 | Hepatocellular necrosis (HP:0001404) | 2.10757243 |
| 100 | Medial flaring of the eyebrow (HP:0010747) | 2.09864176 |
| 101 | Abnormal albumin level (HP:0012116) | 2.08686764 |
| 102 | Hypoalbuminemia (HP:0003073) | 2.08686764 |
| 103 | Abnormal gallbladder physiology (HP:0012438) | 2.08138011 |
| 104 | Cholecystitis (HP:0001082) | 2.08138011 |
| 105 | Congenital primary aphakia (HP:0007707) | 2.07592058 |
| 106 | Limb ataxia (HP:0002070) | 2.07344174 |
| 107 | Postural instability (HP:0002172) | 2.06566715 |
| 108 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.06433657 |
| 109 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.05679449 |
| 110 | Furrowed tongue (HP:0000221) | 2.04409438 |
| 111 | Acute necrotizing encephalopathy (HP:0006965) | 2.03219601 |
| 112 | Absent speech (HP:0001344) | 2.02999890 |
| 113 | Pancreatic cysts (HP:0001737) | 2.02530981 |
| 114 | Nephronophthisis (HP:0000090) | 2.01556131 |
| 115 | Gait ataxia (HP:0002066) | 2.01104461 |
| 116 | Pancreatic fibrosis (HP:0100732) | 2.00994861 |
| 117 | Hypomagnesemia (HP:0002917) | 2.00957723 |
| 118 | True hermaphroditism (HP:0010459) | 2.00533626 |
| 119 | Lipid accumulation in hepatocytes (HP:0006561) | 2.00139890 |
| 120 | Progressive macrocephaly (HP:0004481) | 1.99356350 |
| 121 | Muscular hypotonia of the trunk (HP:0008936) | 1.98133151 |
| 122 | Renal cortical cysts (HP:0000803) | 1.97771828 |
| 123 | Poor suck (HP:0002033) | 1.96814027 |
| 124 | Intention tremor (HP:0002080) | 1.95952196 |
| 125 | Psychosis (HP:0000709) | 1.94054313 |
| 126 | Abnormal hair whorl (HP:0010721) | 1.94008775 |
| 127 | Spastic gait (HP:0002064) | 1.93982180 |
| 128 | Drooling (HP:0002307) | 1.93967308 |
| 129 | Excessive salivation (HP:0003781) | 1.93967308 |
| 130 | Abnormality of saccadic eye movements (HP:0000570) | 1.93001031 |
| 131 | Ventricular fibrillation (HP:0001663) | 1.91627932 |
| 132 | Cortical visual impairment (HP:0100704) | 1.91177314 |
| 133 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.88111340 |
| 134 | Renal Fanconi syndrome (HP:0001994) | 1.87331634 |
| 135 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.87181413 |
| 136 | Delayed gross motor development (HP:0002194) | 1.87061065 |
| 137 | Nephrogenic diabetes insipidus (HP:0009806) | 1.86779662 |
| 138 | Fetal akinesia sequence (HP:0001989) | 1.86415578 |
| 139 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.85368305 |
| 140 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.85368305 |
| 141 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.85368305 |
| 142 | Congenital sensorineural hearing impairment (HP:0008527) | 1.84765677 |
| 143 | Abnormality of the fovea (HP:0000493) | 1.84163648 |
| 144 | Neoplasm of the adrenal gland (HP:0100631) | 1.83526447 |
| 145 | Horizontal nystagmus (HP:0000666) | 1.83443256 |
| 146 | Hypoventilation (HP:0002791) | 1.82873766 |
| 147 | Generalized myoclonic seizures (HP:0002123) | 1.82866488 |
| 148 | Polyphagia (HP:0002591) | 1.82110950 |
| 149 | Respiratory failure (HP:0002878) | 1.81613146 |
| 150 | Abnormality of midbrain morphology (HP:0002418) | 1.81220233 |
| 151 | Molar tooth sign on MRI (HP:0002419) | 1.81220233 |
| 152 | Scotoma (HP:0000575) | 1.80947376 |
| 153 | Downturned corners of mouth (HP:0002714) | 1.80399931 |
| 154 | Mitochondrial inheritance (HP:0001427) | 1.79888471 |
| 155 | Neuronal loss in central nervous system (HP:0002529) | 1.79479460 |
| 156 | Prominent metopic ridge (HP:0005487) | 1.79153235 |
| 157 | Focal dystonia (HP:0004373) | 1.79100345 |
| 158 | Amelogenesis imperfecta (HP:0000705) | 1.77768743 |
| 159 | Mucopolysacchariduria (HP:0008155) | 1.77124030 |
| 160 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.77124030 |
| 161 | Type II lissencephaly (HP:0007260) | 1.77093704 |
| 162 | Diminished movement (HP:0002374) | 1.77064589 |
| 163 | Oligomenorrhea (HP:0000876) | 1.76592922 |
| 164 | Spastic tetraplegia (HP:0002510) | 1.76253745 |
| 165 | Optic disc pallor (HP:0000543) | 1.76063233 |
| 166 | Cerebral edema (HP:0002181) | 1.74873620 |
| 167 | Megalencephaly (HP:0001355) | 1.74725964 |
| 168 | Testicular neoplasm (HP:0010788) | 1.74609001 |
| 169 | Torticollis (HP:0000473) | 1.74542609 |
| 170 | Resting tremor (HP:0002322) | 1.73423147 |
| 171 | Hypothermia (HP:0002045) | 1.73135640 |
| 172 | Limb dystonia (HP:0002451) | 1.71937193 |
| 173 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.71235576 |
| 174 | Spinal canal stenosis (HP:0003416) | 1.70031331 |
| 175 | Hyperthyroidism (HP:0000836) | 1.67341822 |
| 176 | Impaired vibratory sensation (HP:0002495) | 1.67169816 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.08205635 |
| 2 | FGFR2 | 3.93800699 |
| 3 | MAP3K4 | 3.44717594 |
| 4 | MAP2K7 | 3.16990586 |
| 5 | MAP3K9 | 3.06793354 |
| 6 | MINK1 | 3.00093420 |
| 7 | MST4 | 2.86470029 |
| 8 | GRK1 | 2.78663724 |
| 9 | MAP4K2 | 2.58728974 |
| 10 | CASK | 2.36473167 |
| 11 | MAP3K12 | 2.34264819 |
| 12 | PAK6 | 2.30652868 |
| 13 | MAP2K4 | 2.11626439 |
| 14 | NME1 | 2.11169630 |
| 15 | PRPF4B | 1.98042047 |
| 16 | PRKD3 | 1.96042494 |
| 17 | STK38 | 1.94693010 |
| 18 | INSRR | 1.90929458 |
| 19 | CAMKK2 | 1.84209797 |
| 20 | NEK1 | 1.83400451 |
| 21 | FGFR3 | 1.78879067 |
| 22 | GRK5 | 1.73812345 |
| 23 | MARK1 | 1.70088405 |
| 24 | NTRK2 | 1.68703002 |
| 25 | AKT3 | 1.67260813 |
| 26 | ADRBK2 | 1.66462306 |
| 27 | NTRK1 | 1.65941022 |
| 28 | WNK4 | 1.60241740 |
| 29 | EPHA4 | 1.59175093 |
| 30 | ARAF | 1.53364340 |
| 31 | KSR2 | 1.44167451 |
| 32 | CAMKK1 | 1.42688711 |
| 33 | TLK1 | 1.41035119 |
| 34 | PRKCG | 1.40795184 |
| 35 | STK38L | 1.40536761 |
| 36 | EIF2AK1 | 1.39918242 |
| 37 | PLK2 | 1.35708704 |
| 38 | CDK5 | 1.33783006 |
| 39 | CSNK1G1 | 1.31110867 |
| 40 | RIPK1 | 1.29340195 |
| 41 | ACVR1B | 1.27975305 |
| 42 | NLK | 1.27309129 |
| 43 | WNK1 | 1.21601292 |
| 44 | KSR1 | 1.21483080 |
| 45 | CSNK1G3 | 1.20624347 |
| 46 | DAPK1 | 1.20513525 |
| 47 | PNCK | 1.19854723 |
| 48 | YES1 | 1.19084484 |
| 49 | MAP3K13 | 1.18715041 |
| 50 | BMPR1B | 1.17188039 |
| 51 | FES | 1.16476839 |
| 52 | SGK223 | 1.15651337 |
| 53 | SGK494 | 1.15651337 |
| 54 | DAPK2 | 1.13575330 |
| 55 | PRKCH | 1.13246895 |
| 56 | MAP2K6 | 1.13094090 |
| 57 | CDK19 | 1.13029086 |
| 58 | PHKG2 | 1.12139146 |
| 59 | PHKG1 | 1.12139146 |
| 60 | TSSK6 | 1.11617661 |
| 61 | MAP3K2 | 1.10608717 |
| 62 | STK24 | 1.10026338 |
| 63 | ERBB3 | 1.09123647 |
| 64 | PBK | 1.08722945 |
| 65 | SGK2 | 1.07842924 |
| 66 | PDK3 | 1.06123528 |
| 67 | PDK4 | 1.06123528 |
| 68 | CAMK2D | 1.06058320 |
| 69 | CAMK2A | 1.04354631 |
| 70 | PINK1 | 1.01741954 |
| 71 | PRKCE | 1.01474956 |
| 72 | NUAK1 | 1.01461237 |
| 73 | STK39 | 0.99218358 |
| 74 | UHMK1 | 0.99134035 |
| 75 | DYRK1A | 0.98169132 |
| 76 | ZAK | 0.94295500 |
| 77 | MKNK2 | 0.90265536 |
| 78 | CAMK2B | 0.89995253 |
| 79 | TNK2 | 0.89959829 |
| 80 | CDK14 | 0.84955436 |
| 81 | CAMK1 | 0.83642884 |
| 82 | RIPK4 | 0.82586884 |
| 83 | PAK3 | 0.82335230 |
| 84 | BRAF | 0.81124130 |
| 85 | STK16 | 0.80507885 |
| 86 | EPHA3 | 0.79909652 |
| 87 | MAPK13 | 0.79365164 |
| 88 | CDK18 | 0.79327463 |
| 89 | FER | 0.78645635 |
| 90 | SCYL2 | 0.78016653 |
| 91 | SGK3 | 0.77384719 |
| 92 | CDK15 | 0.76486497 |
| 93 | CAMK2G | 0.75609935 |
| 94 | OXSR1 | 0.75498612 |
| 95 | STK3 | 0.75357533 |
| 96 | STK11 | 0.71289828 |
| 97 | ERBB4 | 0.70305557 |
| 98 | PASK | 0.68414382 |
| 99 | PLK3 | 0.66242176 |
| 100 | TNIK | 0.64759013 |
| 101 | PRKAA1 | 0.64545063 |
| 102 | CDK11A | 0.62861804 |
| 103 | PTK2B | 0.62318198 |
| 104 | CDC42BPA | 0.62189100 |
| 105 | HIPK2 | 0.61216976 |
| 106 | FRK | 0.61128832 |
| 107 | EIF2AK3 | 0.60681122 |
| 108 | PRKAA2 | 0.59707053 |
| 109 | TRPM7 | 0.58903630 |
| 110 | LMTK2 | 0.58874630 |
| 111 | MAP3K1 | 0.58650154 |
| 112 | CSNK1A1L | 0.58461405 |
| 113 | SIK3 | 0.56949091 |
| 114 | MUSK | 0.55720975 |
| 115 | SGK1 | 0.55131655 |
| 116 | BMPR2 | 0.54576170 |
| 117 | PRKACA | 0.54250724 |
| 118 | PRKD2 | 0.52832835 |
| 119 | PRKCI | 0.52476139 |
| 120 | RPS6KA3 | 0.51208969 |
| 121 | CDK3 | 0.50287264 |
| 122 | MAP2K1 | 0.50132711 |
| 123 | PDK1 | 0.48803349 |
| 124 | RET | 0.48102912 |
| 125 | NEK6 | 0.47337609 |
| 126 | WNK3 | 0.46071324 |
| 127 | CSNK1A1 | 0.45815366 |
| 128 | LIMK1 | 0.45810988 |
| 129 | PRKCA | 0.44551749 |
| 130 | MAPK10 | 0.43768788 |
| 131 | MARK2 | 0.43571031 |
| 132 | PDK2 | 0.43048689 |
| 133 | PRKCZ | 0.42607252 |
| 134 | PRKG2 | 0.42431258 |
| 135 | CSNK1G2 | 0.42308522 |
| 136 | CSNK1D | 0.41209799 |
| 137 | PRKCB | 0.40922469 |
| 138 | SIK2 | 0.40768647 |
| 139 | ROCK2 | 0.40718579 |
| 140 | PRKG1 | 0.39683316 |
| 141 | ROCK1 | 0.38561962 |
| 142 | PDPK1 | 0.38483671 |
| 143 | STK4 | 0.36269369 |
| 144 | TAOK1 | 0.33055345 |
| 145 | MYLK | 0.31379082 |
| 146 | PRKCQ | 0.28243146 |
| 147 | PRKACB | 0.26678547 |
| 148 | PTK2 | 0.22965035 |
| 149 | IKBKB | 0.21007222 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.95527150 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.90366035 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 3.20826934 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.95914928 |
| 5 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.64335423 |
| 6 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.63075632 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.56418965 |
| 8 | Protein export_Homo sapiens_hsa03060 | 2.55728543 |
| 9 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.54565307 |
| 10 | Circadian entrainment_Homo sapiens_hsa04713 | 2.52661407 |
| 11 | Insulin secretion_Homo sapiens_hsa04911 | 2.36230098 |
| 12 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.33130921 |
| 13 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.30154793 |
| 14 | Long-term potentiation_Homo sapiens_hsa04720 | 2.18686296 |
| 15 | Olfactory transduction_Homo sapiens_hsa04740 | 2.13461717 |
| 16 | Taste transduction_Homo sapiens_hsa04742 | 2.09903718 |
| 17 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.09903713 |
| 18 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.04909417 |
| 19 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.99719320 |
| 20 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.99226700 |
| 21 | Salivary secretion_Homo sapiens_hsa04970 | 1.94352595 |
| 22 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.94065756 |
| 23 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.78391664 |
| 24 | Long-term depression_Homo sapiens_hsa04730 | 1.76845936 |
| 25 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.76429947 |
| 26 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.75810039 |
| 27 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.74020016 |
| 28 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.66337497 |
| 29 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.63425664 |
| 30 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.60360336 |
| 31 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.53826417 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.50497704 |
| 33 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.47979989 |
| 34 | Renin secretion_Homo sapiens_hsa04924 | 1.46916666 |
| 35 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.44827776 |
| 36 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.42668137 |
| 37 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.41341236 |
| 38 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.35807070 |
| 39 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.35708158 |
| 40 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.34921081 |
| 41 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.31514957 |
| 42 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.29951789 |
| 43 | Cocaine addiction_Homo sapiens_hsa05030 | 1.28309364 |
| 44 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.27255166 |
| 45 | Phototransduction_Homo sapiens_hsa04744 | 1.22115098 |
| 46 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.21897156 |
| 47 | Peroxisome_Homo sapiens_hsa04146 | 1.20983206 |
| 48 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.20376710 |
| 49 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.19045520 |
| 50 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.16541566 |
| 51 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.13177265 |
| 52 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.12297362 |
| 53 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.11305468 |
| 54 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.08134142 |
| 55 | Gap junction_Homo sapiens_hsa04540 | 1.08125830 |
| 56 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.07886857 |
| 57 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.06513933 |
| 58 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.03927152 |
| 59 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.03460055 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 1.03095175 |
| 61 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.02765063 |
| 62 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.02201516 |
| 63 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.02085419 |
| 64 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.99957066 |
| 65 | Alzheimers disease_Homo sapiens_hsa05010 | 0.98556975 |
| 66 | Circadian rhythm_Homo sapiens_hsa04710 | 0.98466197 |
| 67 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.96218878 |
| 68 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.95931002 |
| 69 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.94573118 |
| 70 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.94379063 |
| 71 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.93799634 |
| 72 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.92283300 |
| 73 | Parkinsons disease_Homo sapiens_hsa05012 | 0.91846089 |
| 74 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.89064944 |
| 75 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.84373508 |
| 76 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.83367261 |
| 77 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.75605234 |
| 78 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.72414612 |
| 79 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.71446531 |
| 80 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.71296115 |
| 81 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.71284711 |
| 82 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.69299074 |
| 83 | Retinol metabolism_Homo sapiens_hsa00830 | 0.65875307 |
| 84 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.65316527 |
| 85 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.63558911 |
| 86 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.63266674 |
| 87 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.63118493 |
| 88 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.62369623 |
| 89 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.61413846 |
| 90 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.60817424 |
| 91 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.59364997 |
| 92 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.59045023 |
| 93 | Metabolic pathways_Homo sapiens_hsa01100 | 0.58434915 |
| 94 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.58125433 |
| 95 | Melanogenesis_Homo sapiens_hsa04916 | 0.57356652 |
| 96 | Glioma_Homo sapiens_hsa05214 | 0.57042200 |
| 97 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.56838368 |
| 98 | Huntingtons disease_Homo sapiens_hsa05016 | 0.54898674 |
| 99 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.53354731 |
| 100 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.52382561 |
| 101 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.51405092 |
| 102 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50788340 |
| 103 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.50647669 |
| 104 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.49252739 |
| 105 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.47400132 |
| 106 | Bile secretion_Homo sapiens_hsa04976 | 0.46651674 |
| 107 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.46512905 |
| 108 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.46206985 |
| 109 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44651531 |
| 110 | Alcoholism_Homo sapiens_hsa05034 | 0.44138047 |
| 111 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.43680359 |
| 112 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.41868629 |
| 113 | Lysosome_Homo sapiens_hsa04142 | 0.41049686 |
| 114 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.40131789 |
| 115 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.39561548 |
| 116 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.37256240 |
| 117 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.35457765 |
| 118 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.34434192 |
| 119 | Axon guidance_Homo sapiens_hsa04360 | 0.33847291 |
| 120 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.33520700 |
| 121 | Purine metabolism_Homo sapiens_hsa00230 | 0.33294837 |
| 122 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.33000154 |
| 123 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.32641987 |
| 124 | Phagosome_Homo sapiens_hsa04145 | 0.32417800 |
| 125 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.32348088 |
| 126 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.31879935 |
| 127 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.30671874 |
| 128 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.30510702 |
| 129 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.29929168 |
| 130 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.29574157 |
| 131 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.28901720 |
| 132 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.28683625 |
| 133 | Endocytosis_Homo sapiens_hsa04144 | 0.28290137 |
| 134 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.26754249 |
| 135 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.25635288 |
| 136 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.24181727 |
| 137 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.23444895 |
| 138 | Mineral absorption_Homo sapiens_hsa04978 | 0.21827641 |

